Genematch for preclinical Alzheimer’s disease clinical studies

Patient Qualifications

Min Age Max Age Gender Healthy Volunteers
55 Years
75 Years
Both
Accepts Healthy Volunteers

Inclusion Criteria

    • Willing to provide basic demographic, medical history, and contact information
    • Consent to APOE genotyping without receiving results
    • Resident of the United States

Exclusion Criteria

    • Unable to comply with GeneMatch requirements
    • Self-reported diagnosis of dementia or any other objective cognitive impairment syndrome

Detailed Description

The primary purpose of GeneMatch is to identify and characterize a large group of people who are interested in, and may be eligible to participate in, preclinical Alzheimer’s disease clinical studies and trials based on their genetic background. Participation in these research studies is voluntary.

GeneMatch will provide a cheek swab kit for collecting a genetic sample to determine which copies of the apolipoprotein E (APOE) gene a person has. GeneMatch will use the APOE test results to match enrollees to research studies they may be interested in. GeneMatch will not disclose the results of the APOE test to enrollees, but studies to which enrollees are referred may require such disclosure. All information will remain secure and confidential.

Central Contact Information:

For more information, visit www.endALZnow.org/GeneMatch, or call 1-888-786-7259or email GeneMatch@endALZnow.org

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.